Cargando…

Estimation of renal cell carcinoma treatment effects from disease progression modeling

To improve future drug development efficiency in renal cell carcinoma (RCC), a disease progression model was developed with longitudinal tumor size data from a phase III trial of sorafenib in RCC. The best fit model was externally evaluated on 145 placebo-treated patients in a phase III trial of paz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maitland, Michael L., Wu, Kehua, Sharma, Manish R., Jin, Yuyan, Kang, Soonmo Peter, Stadler, Walter M., Karrison, Theodore G., Ratain, Mark J., Bies, Robert R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791430/ https://www.ncbi.nlm.nih.gov/pubmed/23443753 http://dx.doi.org/10.1038/clpt.2012.263

Ejemplares similares

Models of Excellence: Improving Oncology Drug Development
por: Sharma, Manish R., et al.
Publicado: (2012)

Sorafenib Dose Escalation is Not Uniformly Associated with Blood Pressure Elevations in Normotensive Patients with Advanced Malignancies
por: Karovic, Sanja, et al.
Publicado: (2014)

Comparative Effects of CT Imaging Measurement on RECIST End Points and Tumor Growth Kinetics Modeling
por: Li, CH, et al.
Publicado: (2016)

WHSC1L1 drives cell cycle progression through transcriptional regulation of CDC6 and CDK2 in squamous cell carcinoma of the head and neck
por: Saloura, Vassiliki, et al.
Publicado: (2016)

Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials?
por: Karrison, Theodore, et al.
Publicado: (2018)

Nonlinear Population Pharmacokinetics of Sirolimus in Patients With Advanced Cancer
por: Wu, K, et al.
Publicado: (2012)

A randomized phase II study of pazopanib in hormone sensitive prostate cancer: a University of Chicago Phase II Consortium/ Department of Defense Prostate Cancer Clinical Trials Consortium study
por: Ward, James E., et al.
Publicado: (2011)

D-dimer and risk for thrombosis in adults with newly diagnosed acute lymphoblastic leukemia
por: Anderson, Daniela R., et al.
Publicado: (2022)

Global variation in CYP2C8–CYP2C9 functional haplotypes
por: Speed, William C, et al.
Publicado: (2009)

Estimating parameters of nonlinear dynamic systems in pharmacology using chaos synchronization and grid search
por: Pillai, Nikhil, et al.
Publicado: (2019)

Extrusion Characteristics of Thin Walled Tubes for Catheters Using Thermoplastic Elastomer
por: Cho, Soonmo, et al.
Publicado: (2020)

Immunological perspective on the malignant progression of renal clear cell carcinoma
por: Liu, Ji, et al.
Publicado: (2021)

Sequential Therapy in Metastatic Renal Cell Carcinoma
por: Hirsch, Bradford R., et al.
Publicado: (2016)

Lurbinectedin-induced thrombocytopenia: the role of body surface area
por: Papachristos, Apostolos, et al.
Publicado: (2022)

Complete response of renal cell carcinoma vena cava tumor thrombus to neoadjuvant immunotherapy
por: Labbate, Craig, et al.
Publicado: (2019)

Human renal adipose tissue induces the invasion and progression of renal cell carcinoma
por: Campo-Verde-Arbocco, Fiorella, et al.
Publicado: (2017)

Research progress on advanced renal cell carcinoma
por: Song, Xin-da, et al.
Publicado: (2020)

Editorial: Influences in the progression of renal cell carcinoma
por: Bacchiani, Mara, et al.
Publicado: (2022)

Drug Interactions With a Short Course of Nirmatrelvir and Ritonavir: Prescribers and Patients Beware
por: Ratain, Mark J., et al.
Publicado: (2022)

Deep Learning Methods Applied to Drug Concentration Prediction of Olanzapine
por: Khusial, Richard, et al.
Publicado: (2023)

Progression of renal cell carcinoma is inhibited by genistein and radiation in an orthotopic model
por: Hillman, Gilda G, et al.
Publicado: (2007)

Outcomes and Quality of Life of Systemic Therapy in Advanced Hepatocellular Carcinoma
por: Zhou, Kehua, et al.
Publicado: (2019)

Methylation-related genes involved in renal carcinoma progression
por: Zamora-Fuentes, Jose María, et al.
Publicado: (2023)

Steroid-refractory dermatologic and pulmonary toxicity in a patient on rituximab treated with pembrolizumab for progressive urothelial carcinoma: a case report
por: Hines, Jacobi, et al.
Publicado: (2021)

Validation of a New Bowel Preparation Scale for Measuring Colon Cleansing for Colonoscopy: The Chicago Bowel Preparation Scale
por: Gerard, David P, et al.
Publicado: (2013)

An approach to estimating prognosis using fractional polynomials in metastatic renal carcinoma
por: Royston, P, et al.
Publicado: (2006)

Application of dynamic modeling for survival estimation in advanced renal cell carcinoma
por: Deniz, Baris, et al.
Publicado: (2018)

Oxymatrine Inhibits Renal Cell Carcinoma Progression by Suppressing β-Catenin Expression
por: Jin, Yinshan, et al.
Publicado: (2020)

The HapMap Resource is Providing New Insights into Ourselves and its Application to Pharmacogenomics
por: Zhang, Wei, et al.
Publicado: (2008)

The dosing of ibrutinib and related Bruton’s tyrosine kinase inhibitors: eliminating the use of brute force
por: Ratain, Mark J., et al.
Publicado: (2022)

Exact vs. Approximate Computation: Reconciling Different Estimates of Mycobacterium tuberculosis Epidemiological Parameters
por: Aandahl, R. Zachariah, et al.
Publicado: (2014)

YTHDC1 Promotes Stemness Maintenance and Malignant Progression in Head and Neck Squamous Cell Carcinoma
por: Weng, Junquan, et al.
Publicado: (2022)

Fructose-1, 6-bisphosphatase opposes renal carcinoma progression
por: Li, Bo, et al.
Publicado: (2014)

Progress of Molecular Targeted Therapies for Advanced Renal Cell Carcinoma
por: Conti, Alessandro, et al.
Publicado: (2013)

Rapid recurrence and radiographic progression of sarcomatoid renal cell carcinoma
por: Edelson, Mia P., et al.
Publicado: (2017)

Pyk2 promotes tumor progression in renal cell carcinoma
por: Zhao, Tangliang, et al.
Publicado: (2018)

PYCR1 is Associated with Papillary Renal Cell Carcinoma Progression
por: Wang, Qiu-Li, et al.
Publicado: (2019)

Glutathione Metabolism in Renal Cell Carcinoma Progression and Implications for Therapies
por: Xiao, Yi, et al.
Publicado: (2019)

PON1 hypermethylation is associated with progression of renal cell carcinoma
por: Li, Xin, et al.
Publicado: (2019)

Siglec-15 promotes progression of clear renal cell carcinoma
por: Yang, Wen-Bo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kph4jt2jns35vbh580tu3ksnum